ONTOLOGY REPORT - ANNOTATIONS
| Term: | Carcinoma, Pancreatic Ductal |
|
| Accession: | RDO:0007458
|
browse the term
|
| Definition: | Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS. |
| Synonyms: | exact_synonym: | Duct Cell Carcinoma of the Pancreas; Ductal Carcinoma of the Pancreas; Pancreas Duct-Cell Carcinoma; Pancreas Duct-Cell Carcinomas; Pancreatic Duct Cell Carcinoma; Pancreatic Ductal Carcinomas |
| | primary_id: | MESH:D021441 |
|
|
Carcinoma, Pancreatic Ductal
|
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
ISS |
10 |
95,361,338 |
95,381,455 |
RGD:2325211 |
RGD |
| G |
Ace2 |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
|
|
ISS |
X |
51,051,758 |
51,096,036 |
RGD:2325210 |
RGD |
| G |
Adam8 |
ADAM metallopeptidase domain 8 |
|
Disease_progression |
ISS |
1 |
199,780,772 |
199,791,855 |
RGD:2325243 |
RGD |
| G |
Adam9 |
ADAM metallopeptidase domain 9 |
|
Disease_progression |
ISS |
16 |
71,446,498 |
71,526,108 |
RGD:2325249 |
RGD |
| G |
Agr2 |
anterior gradient 2 homolog (Xenopus laevis) |
|
|
ISS |
6 |
54,695,633 |
54,716,858 |
RGD:2325659 |
RGD |
| G |
Alb |
albumin |
|
Disease_progression |
ISS |
14 |
19,126,935 |
19,142,214 |
RGD:2325677 |
RGD |
| G |
Anxa2 |
annexin A2 |
|
|
ISS |
8 |
73,897,618 |
73,934,041 |
RGD:2325731 |
RGD |
| G |
Anxa2 |
annexin A2 |
|
Disease_progression |
ISS |
8 |
73,897,618 |
73,934,041 |
RGD:2317307 |
RGD |
| G |
Anxa5 |
annexin A5 |
|
|
ISS |
2 |
122,949,210 |
122,979,757 |
RGD:2317538 |
RGD |
| G |
Anxa8 |
annexin A8 |
|
|
ISS |
16 |
9,715,644 |
9,730,584 |
RGD:2325735 |
RGD |
| G |
Apoc1 |
apolipoprotein C-I |
|
|
ISS |
1 |
78,996,677 |
78,999,960 |
RGD:2325793 |
RGD |
| G |
Calr |
calreticulin |
|
|
ISS |
19 |
24,964,775 |
24,969,670 |
RGD:2326165 |
RGD |
| G |
Cckar |
cholecystokinin A receptor |
|
|
ISS |
14 |
62,052,510 |
62,057,201 |
RGD:4110816 |
RGD |
| G |
Cckar |
cholecystokinin A receptor |
|
|
ISS |
14 |
62,052,510 |
62,057,201 |
RGD:4110818 |
RGD |
| G |
Cckbr |
cholecystokinin B receptor |
|
|
ISS |
1 |
163,156,914 |
163,166,969 |
RGD:4110816 |
RGD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
|
ISS |
3 |
156,092,602 |
156,107,427 |
RGD:5490301 |
RGD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
|
ISS |
3 |
156,092,602 |
156,107,427 |
RGD:5490524 |
RGD |
| G |
Cldn4 |
claudin 4 |
|
|
ISS |
12 |
22,816,134 |
22,817,932 |
RGD:2317592 |
RGD |
| G |
Egf |
epidermal growth factor |
|
Disease_progression |
ISS |
2 |
227,103,900 |
227,195,062 |
RGD:2317644 |
RGD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
|
ISS |
13 |
77,472,950 |
77,480,210 |
RGD:2317747 |
RGD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
|
ISS |
13 |
77,472,950 |
77,480,210 |
RGD:2317741 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
Disease_progression |
ISS |
2 |
123,893,314 |
123,947,136 |
RGD:2317758 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISS |
2 |
123,893,314 |
123,947,136 |
RGD:2317756 |
RGD |
| G |
Fscn1 |
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) |
|
Disease_progression |
ISS |
|
|
|
RGD:2317790 |
RGD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
|
ISS |
1 |
206,627,398 |
206,629,866 |
RGD:2317809 |
RGD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
|
ISS |
1 |
206,627,398 |
206,629,866 |
RGD:2317811 |
RGD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
Resistance |
ISS |
1 |
206,627,398 |
206,629,866 |
RGD:2317806 |
RGD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
|
ISS |
7 |
24,531,669 |
24,605,742 |
RGD:2317639 |
RGD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
|
ISS |
1 |
122,704,976 |
122,990,007 |
RGD:2317649 |
RGD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
|
ISS |
1 |
122,704,976 |
122,990,007 |
RGD:2317652 |
RGD |
| G |
Il4 |
interleukin 4 |
|
|
ISS |
10 |
39,074,582 |
39,080,134 |
RGD:2317264 |
RGD |
| G |
Il4r |
interleukin 4 receptor |
|
|
ISS |
1 |
184,612,903 |
184,637,863 |
RGD:2317264 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:2317248 |
RGD |
| G |
Krt7 |
keratin 7 |
|
Disease_progression |
ISS |
7 |
140,160,829 |
140,226,474 |
RGD:2317307 |
RGD |
| G |
L1cam |
L1 cell adhesion molecule |
|
Severity |
ISS |
X |
159,784,792 |
159,801,553 |
RGD:6483447 |
RGD |
| G |
Mcm7 |
minichromosome maintenance complex component 7 |
|
|
ISS |
12 |
17,607,250 |
17,614,508 |
RGD:2317697 |
RGD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
Severity |
ISS |
7 |
56,996,694 |
57,020,926 |
RGD:2317416 |
RGD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
Onset |
ISS |
7 |
56,996,694 |
57,020,926 |
RGD:2317414 |
RGD |
| G |
Men1 |
multiple endocrine neoplasia I |
|
|
ISS |
1 |
209,114,987 |
209,120,837 |
RGD:2317294 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
ISS |
4 |
43,134,183 |
43,211,355 |
RGD:2317530 |
RGD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
Susceptibility |
ISS |
1 |
196,629,366 |
196,866,937 |
RGD:2317648 |
RGD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
|
ISS |
1 |
196,629,366 |
196,866,937 |
RGD:2317664 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
Severity |
ISS |
19 |
15,246,036 |
15,275,061 |
RGD:2325746 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:2325844 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:2325830 |
RGD |
| G |
Msln |
mesothelin |
|
|
ISS |
10 |
15,017,162 |
15,022,823 |
RGD:2326065 |
RGD |
| G |
Msln |
mesothelin |
|
Disease_progression |
ISS |
10 |
15,017,162 |
15,022,823 |
RGD:2326055 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
|
ISS |
2 |
181,399,482 |
181,403,640 |
RGD:2317983 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
Disease_progression |
ISS |
2 |
181,399,482 |
181,403,640 |
RGD:2324633 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
Disease_progression |
ISS |
2 |
181,399,482 |
181,403,640 |
RGD:2324616 |
RGD |
| G |
Muc3a |
mucin 3A, cell surface associated |
|
Disease_progression |
ISS |
|
|
|
RGD:2324946 |
RGD |
| G |
Muc4 |
mucin 4, cell surface associated |
|
|
ISS |
11 |
69,830,276 |
69,858,366 |
RGD:2324946 |
RGD |
| G |
Muc4 |
mucin 4, cell surface associated |
|
Disease_progression |
ISS |
11 |
69,830,276 |
69,858,366 |
RGD:2324942 |
RGD |
| G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
|
ISS |
|
|
|
RGD:2324986 |
RGD |
| G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
Disease_progression |
ISS |
|
|
|
RGD:2324907 |
RGD |
| G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
|
|
ISS |
1 |
201,962,340 |
201,997,147 |
RGD:2324986 |
RGD |
| G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
|
|
ISS |
10 |
82,591,705 |
82,601,075 |
RGD:5132867 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:2325254 |
RGD |
| G |
Notch1 |
notch 1 |
|
|
ISS |
3 |
4,631,797 |
4,677,640 |
RGD:2325323 |
RGD |
| G |
Notch1 |
notch 1 |
|
|
ISS |
3 |
4,631,797 |
4,677,640 |
RGD:2325324 |
RGD |
| G |
Ntrk3 |
neurotrophic tyrosine kinase, receptor, type 3 |
|
Disease_progression |
ISS |
1 |
133,925,530 |
134,302,139 |
RGD:2325660 |
RGD |
| G |
Ntrk3 |
neurotrophic tyrosine kinase, receptor, type 3 |
|
|
ISS |
1 |
133,925,530 |
134,302,139 |
RGD:2325663 |
RGD |
| G |
Palld |
palladin, cytoskeletal associated protein |
|
|
ISS |
16 |
31,144,028 |
31,144,544 |
RGD:2325781 |
RGD |
| G |
Pms1 |
postmeiotic segregation increased 1 (S. cerevisiae) |
|
|
ISS |
9 |
45,203,344 |
45,292,624 |
RGD:2324870 |
RGD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
Disease_progression |
ISS |
4 |
151,492,220 |
151,617,331 |
RGD:2317461 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
ISS |
13 |
64,427,288 |
64,432,978 |
RGD:2317185 |
RGD |
| G |
Rxra |
retinoid X receptor alpha |
|
Severity |
ISS |
3 |
6,605,782 |
6,689,224 |
RGD:2317461 |
RGD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
|
ISS |
6 |
127,998,617 |
128,021,719 |
RGD:2317811 |
RGD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
|
ISS |
2 |
116,036,501 |
116,065,834 |
RGD:2324975 |
RGD |
| G |
Smo |
smoothened, frizzled family receptor |
|
|
ISS |
4 |
56,623,494 |
56,645,571 |
RGD:2324981 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
Disease_progression |
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:2325019 |
RGD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
Disease_progression |
ISS |
8 |
120,593,595 |
120,680,453 |
RGD:2317500 |
RGD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
|
ISS |
8 |
120,593,595 |
120,680,453 |
RGD:2317498 |
RGD |
| G |
Thbs1 |
thrombospondin 1 |
|
Disease_progression |
ISS |
|
|
|
RGD:2325025 |
RGD |
| G |
Thbs1 |
thrombospondin 1 |
|
|
ISS |
|
|
|
RGD:2325022 |
RGD |
| G |
Tmprss3 |
transmembrane protease, serine 3 |
|
|
ISS |
20 |
9,545,077 |
9,564,261 |
RGD:2325152 |
RGD |
| G |
Tymp |
thymidine phosphorylase |
|
Disease_progression |
ISS |
7 |
127,666,518 |
127,671,624 |
RGD:2325155 |
RGD |
| G |
Vhl |
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase |
|
|
ISS |
4 |
149,529,396 |
149,536,289 |
RGD:2325022 |
RGD |
Term paths to the root
|